Dok Hyun Yoon
University of Ulsan
322 Papers
862 Citations
Dok Hyun Yoon is an academic researcher from University of Ulsan. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 30, co-authored 247 publications.
Chat about Author
Papers
Increased circulating plasma cells detected by flow cytometry predicts poor prognosis in patients with plasma cell myeloma
Mi Hyun Bae,Chan Jeoung Park,Bohyun Kim,Young Uk Cho,Seongsoo Jang,Donghyun Lee,Eul Ju Seo,Dok Hyun Yoon,Jung-Hee Lee,Cheolwon Suh +9 more
TL;DR: This work investigated the prognostic implication of cPCs quantified using a simple panel in patients with PCM and found no evidence of a prognostic effect of circulating PCs.
18
Clinical significance of the appearance of abnormal protein band in patients with multiple myeloma
Jae Cheol Jo,Dok Hyun Yoon,Shin Kim,Kyoungmin Lee,Eun Hee Kang,Seongsoo Jang,Chan Jeoung Park,Hyun Sook Chi,Jooryung Huh,Chan-Sik Park,Cheolwon Suh +10 more
TL;DR: Multivariate analysis indicated that the development of APB was a significant favorable prognostic factor for OS (hazard ratio 0.21; 95 % confidence interval 0.08–0.52).
18
First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma Using Immunochemotherapy and Central Nervous System Prophylaxis: A Multicenter Phase 2 Trial
Ho-Young Yhim,Dok Hyun Yoon,Seok Jin Kim,Deok-Hwan Yang,Hyeon-Seok Eom,Kyoung Ha Kim,Yong Park,Jin Seok Kim,Hyo Jung Kim,Cheolwon Suh,Won Seog Kim,Jae-Yong Kwak +11 more
TL;DR: Although standard R-CHOP and IT-MTX without routine radiotherapy show clinically meaningful survival outcomes, this strategy may not be optimal for reducing CNS relapse and warrants further investigation.
18
Interim 18 F-FGD PET/CT may not predict the outcome in primary central nervous system lymphoma patients treated with sequential treatment with methotrexate and cytarabine
Jae Cheol Jo,Dok Hyun Yoon,Shin Kim,Kyoungmin Lee,Eun Hee Kang,Jung Sun Park,Jin-Sook Ryu,Jooryung Huh,Chan-Sik Park,Jong Hoon Kim,Sang-wook Lee,Cheolwon Suh +11 more
TL;DR: I-PET/CT may not predict the survival outcome of PCNSL patients with DLBCL treated with intensive methotrexate and cytarabine chemotherapy and Prospective trials are required to fully evaluate the role of I- PET/CT.
18
FDG-PET as a potential tool for selecting patients with advanced non-small cell lung cancer who may be spared maintenance therapy after first-line chemotherapy
Dok Hyun Yoon,Sora Baek,Chang-Min Choi,Dae Ho Lee,Cheolwon Suh,Jin-Sook Ryu,Dae Hyuk Moon,Jung Shin Lee,Sang We Kim +8 more
TL;DR: Fractional decrease in SUVmax of the main lesion after completion of 4 cycles of chemotherapy may discriminate patients with TTP ≥8 weeks and predict TTP and OS in patients with advanced NSCLC.
17